Company: SXTPW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003343
Chunk: 1508

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 6
Chunk 1508
---
, and pharmacovigilance requirements. Dr. Dow has also
published a number of important safety reviews, clinical trials, non-clinical studies, on which he was a thought leader or contributor,
which dispelled many of the myths about 8-aminoquinolines. As a scientist, experienced industry project manager and inventor, Dr. Dow’s
ultimate goal is to develop and secure the regulatory approval and commercial success of products, old and new, for new indications in
infectious disease. Dr. Dow received a B.Sc. (Hons) in Veterinary and Biomedical Science from Murdoch University, Perth, Western Australia
(“Murdoch”) in 1994, a Ph.D. in Veterinary and Biomedical Science from Murdoch in 2000 and an MBA from the University of
Maryland at College Park in 2012. We believe that Mr. Dow is well qualified to serve as a Director given his product development experience
in tropical diseases.

Tyrone Miller is our Chief Financial
Officer. Mr. Miller joined us in 2014 and has held a number of roles since then, including Treasurer. He worked with the founder and
Chief Executive Officer of 60P and raised over $6 million in external financing. Mr. Miller also established a multinational financial
reporting system and worked with consultants in designing tax and credit strategies. He also provides key strategic advice in areas of
financing and business planning to 60P. In addition, he is the founder and Principal of Tax & Accounting Practice at Miller Tax &
Advisory since 2011. In that role, Mr. Miller advises owners of closely held businesses on accounting, financial and tax matters and
has designed accounting systems for private sector businesses. From 2002 to 2011, he was a Senior Accountant at Sachs Figurelli, LLC,
where he prepared and processed corporate and individual tax returns, consulted on reengineering accounting processes for construction,
restaurant and professional services businesses and managed staff in preparation and processing of payroll and personal property returns.
Mr. Miller is currently a Certified Public Accountant. He received a Bachelor’s of Business Administration with a concentration
in International Business from Emory University in 1996.

Kristen Landon is our Chief Commercial
Officer. Ms. Landon joined us in 2024 and brings over 26 years’ experience building and transforming pharmaceutical brands in both
start-up and large multinational companies. Ms. Landon has launched and relaunched over a dozen brands